JAGSONPAL PHARMACEUTICALS LTD. Q4 FY25 Results
JAGSNPHARMQ4 FY25 ResultsAnnounced 6 May 2025, 07:28 pm| Metric | Value (₹ Cr) | vs Q3 FY25 |
|---|---|---|
| Revenue | 58.56 | 20.9% |
| Total Income | 61.33 | 19.7% |
| Expenditure | 52.41 | 13.9% |
| PBT | 8.71 | 77.5% |
| Net Profit | 6.58 | 79.4% |
| OPM | 14.52% | 30.98pp |
| NPM | 10.73% | 31.17pp |
| EPS | 0.98 | 79.3% |
Informational and educational content only. Not investment advice.